Global Cell Therapy Market 2022-2028

April 2022 | 85 pages | ID: GCF71347491CEN
Gen Consulting Company

Abstracts

Cellular therapy (CT) is the transplantation of human cells to replace or repair damaged tissue and/or cells. With new technologies, innovative products, and limitless imagination, many different types of cells may be used as part of a therapy or treatment for a variety of diseases and conditions. Projected to expand at a CAGR of 6.3% from 2022 to 2028, the global cell therapy market will worth USD 10,481 million by 2028-end, according to Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global cell therapy market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the cell therapy industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the therapy type, product, application, end user, and region. The global market for cell therapy can be segmented by therapy type: allogeneic, autologous. Cell therapy market is further segmented by product: consumables, equipment, systems and software. Based on application, the cell therapy market is segmented into: cardiovascular, dermatology and wounds, malignancies, musculoskeletal disorders, others. On the basis of end user, the cell therapy market also can be divided into: research institutes, hospitals & clinics, others. Cell therapy market by region is categorized into: North America, Asia Pacific, Europe, Rest of the World (ROW).

By therapy type:

• allogeneic
• autologous

By product:

• consumables
• equipment
• systems and software

By application:

• cardiovascular
• dermatology and wounds
• malignancies
• musculoskeletal disorders
• others

By end user:

• research institutes
• hospitals & clinics
• others

By region:

• North America
• Asia Pacific
• Europe
• Rest of the World (ROW)

The global cell therapy market report offers detailed information on several market vendors, including Allogene Therapeutics, Inc., Castle Creek Biosciences, Inc., Cells for Cells S.A., Dendreon Pharmaceuticals, Inc., JCR Pharmaceuticals Co., Ltd., Juno Therapeutics Inc (Bristol Myers Squibb Co.), Kite Pharma, Inc. (Gilead Sciences, Inc.), Medipost Co., Ltd., Mesoblast Limited, Nipro Corporation, Novartis International AG, NuVasive, Inc., Organogenesis Holdings Inc., Smith & Nephew plc (Osiris Therapeutics, Inc.), Stemedica Cell Technologies, Inc., Stempeutics Research Pvt. Ltd., Takeda Pharmaceutical Company Limited, Vericel Corporation, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global cell therapy market.
• To classify and forecast the global cell therapy market based on therapy type, product, application, end user, region.
• To identify drivers and challenges for the global cell therapy market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global cell therapy market.
• To identify and analyze the profile of leading players operating in the global cell therapy market.

Why Choose This Report

• Gain a reliable outlook of the global cell therapy market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY THERAPY TYPE

Allogeneic
Autologous

PART 6. MARKET BREAKDOWN BY PRODUCT

Consumables
Equipment
Systems and software

PART 7. MARKET BREAKDOWN BY APPLICATION

Cardiovascular
Dermatology and wounds
Malignancies
Musculoskeletal disorders
Others

PART 8. MARKET BREAKDOWN BY END USER

Research institutes
Hospitals & clinics
Others

PART 9. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 10. KEY COMPANIES

Allogene Therapeutics, Inc.
Castle Creek Biosciences, Inc.
Cells for Cells S.A.
Dendreon Pharmaceuticals, Inc.
JCR Pharmaceuticals Co., Ltd.
Juno Therapeutics Inc (Bristol Myers Squibb Co.)
Kite Pharma, Inc. (Gilead Sciences, Inc.)
Medipost Co., Ltd.
Mesoblast Limited
Nipro Corporation
Novartis International AG
NuVasive, Inc.
Organogenesis Holdings Inc.
Smith & Nephew plc (Osiris Therapeutics, Inc.)
Stemedica Cell Technologies, Inc.
Stempeutics Research Pvt. Ltd.
Takeda Pharmaceutical Company Limited
Vericel Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER